Okasha K
Department of Internal Medicine/Nephrology Division,Faculty of medicine, Tanta University, Tanta , Egypt

Shahba A
Department of Internal Medicine/Nephrology Division, Faculty of medicine, Tanta University, Tanta, Egypt

Noor-eldeen NM
Department of Internal Medicine/Nephrology Division, Faculty of medicine, Tanta University, Tanta, Egypt

Hassan AM
Department of Microbiology, Faculty of medicine, Tanta University, Tanta, Egypt

saadany HE
Department of Physical medicine, Rheumatology and Rehabilitation, Faculty of medicine, Tanta University, Tanta, Egypt

Bendary AE
Department of Clinical Pathology, Faculty of medicine, Tanta University, Tanta, Egypt

Correspondence:

Kamal Okasha, M.D.
Department: Department of Internal Medicine/Nephrology Division,Faculty of medicine, Tanta University
City: Tanta
Country: Egypt
E-mail: okasha70@yahoo.com

1. Krishnan S, Chowdhury B, Tsokos GC. Autoimmunity in systemic lupus erythematosus: integrating genes and biology. Semin Immunol. 2006;18:230-43.

2. Nauta AJ, Daha MR, van Kooten C, Roos A. Recognition and clearance of apoptotic cells: a role for complement and pentraxins. Trends Immunol. 2003;24:148-54.

3. Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport  MJ. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol. 2000;76:227-324.

4. Seelen MA, Trouw LA, van der Hoorn JW, Fallaux-van den Houten FC, Huizinga TW, Daha MR, et al. Autoantibodies against mannose-binding lectin in systemic lupus erythematosus. Clin Exp Immunol. 2003;134:335-43.

5. Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD. Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis. 2000;35:904-14.

6. Jakab L, Laki J, Sallai K, et al. Association between early onset and organ manifestations of systemic lupus erythematosus (SLE) and a down-regulating promoter polymorphism in the MBL2 gene. Clin Immunol. 2007;125:230-6.

7. Font J, Ramos-Casals M, Brito-Zeron P, et al. Association of mannose-binding lectin gene polymorphisms with antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2007;46:76-80.

8. Zundel S, Cseh S, Lacroix M, et al. Characterization of recombinant mannan-binding lectin-associated serine protease (MASP)-3 suggests an activation mechanism different from that of MASP-1 and MASP-2. The Journal of Immunology. 2004;172:4342.

9. Messias Reason IJ, Schafranski MD, Jensenius JC, Steffensen R. The association between mannose-binding lectin gene polymorphism and rheumatic heart disease. Hum Immunol. 2006;67:991-8.

10. Sorensen CM, Hansen TK, Steffensen R, Jensenius JC, Thiel S. Hormonal regulation of mannan-binding lectin synthesis in hepatocytes. Clin Exp Immunol. 2006;145:173-82.

11. Ivanova M, Ruiqing J, Matsushita M, et al. MBL2 single nucleotide polymorphism diversity among four ethnic groups as revealed by a bead-based liquid array profiling. Hum Immunol. 2008;69:877-84.

12. Wiertsema SP, Herpers BL, Veenhoven RH, et al. Functional polymorphisms in the mannan-binding lectin 2 gene: effect on MBL levels and otitis media. J Allergy Clin Immunol. 2006;117:1344-50.

13. Seelen M, Van der Bijl E, Trouw L, et al. A role for mannose-binding lectin dysfunction in generation of autoantibodies in systemic lupus erythematosus. Rheumatology. 2005;44:111.

14. Bouwman LH, Roep BO, Roos A. Mannose-binding lectin: clinical implications for infection,  ransplantation, and autoimmunity. Hum Immunol. 2006;67:247-56.

15. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.

16. Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29:288-91.

17. Grande JP, Balow JE. Renal biopsy in lupus nephritis. Lupus. 1998;7:611-7.

18. Garred P, J JS, Quist L, Taaning E, Madsen HO. Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Infect Dis. 2003;188:1394-403.

19. Saevarsdottir S, Oskarsson OO, Aspelund T, et al. Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk. J Exp Med. 2005;201:117-25.

20. Ogden CA, deCathelineau A, Hoffmann PR, et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med. 2001;194:781-95.

21. Piao W, Liu CC, Kao AH, et al. Mannose-binding lectin is a disease-modifying factor in North American patients with systemic lupus erythematosus. J Rheumatol. 2007;34:1506-13.

22. Lipscombe RJ, Sumiya M, Hill AV, et al. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet. 1992;1:709-15.

23. Kilpatrick DC. Mannan-binding lectin: clinical significance and applications. Biochim Biophys Acta. 2002;1572:401- 13.

24. Swierzko AS, Szala A, Cedzynski M, et al. Mannanbinding lectin genotypes and genotype-phenotype relationships in a large cohort of Polish neonates. Hum Immunol. 2009;70:68-72.

25. Lee SG, Yum JS, Moon HM, et al. Analysis of mannose-binding lectin 2 (MBL2) genotypeand the serum protein levels in the Korean population. Mol Immunol. 2005;42:969-77.

26. Ohlenschlaeger T, Garred P, Madsen HO, Jacobsen S. Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med. 2004;351:260-7.

27. Horiuchi T, Tsukamoto H, Morita C, et al. Mannose binding lectin (MBL) gene mutation is not a risk factor for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in Japanese. Immun. 2000;1:464-6.

28. Momot T, Ahmadi-Simab K, Gause A, et al. Lack of association of mannose binding lectin variant alleles with systemic lupus erythematosus. Ann Rheum Dis. 2006;65:278-9.

29. Tsai YC, Yao TC, Kuo ML, Cheng TT, Huang JL. Lack of association of mannose-binding lectin gene polymorphisms with development and clinical manifestations of systemic lupus erythematosus in Chinese children. Lupus. 2009;18:372-6.

30. Lau YL, Lau CS, Chan SY, Karlberg J, Turner MW. Mannose-binding protein in Chinese patients with systemic lupus erythematosus. Arthritis Rheum. 1996;39:706-8.

31. Sullivan KE, Wooten C, Goldman D, Petri M. Mannosebinding protein genetic polymorphisms in black patients with systemic lupus erythematosus. Arthritis Rheum. 1996;39:2046-51.

32. Tsutsumi A, Sasaki K, Wakamiya N, et al. Mannosebinding lectin gene: polymorphisms in Japanese patients with systemic lupus erythematosus, rheumatoid arthritis and Sjogren's syndrome. Genes  mmun. 2001;2:99-104.

33. Takahashi R, Tsutsumi A, Ohtani K, et al. Association of mannose binding lectin (MBL) gene polymorphism and serum MBL concentration with characteristics and progression of systemic lupus erythematosus. Ann Rheum Dis. 2005;64:311-4.

34. Garred P, Madsen HO, Kurtzhals JA, et al. Diallelic polymorphism may explain variations of the blood concentration of mannan-binding protein in Eskimos, but not in black Africans. Eur J Immunogenet. 1992;19:403-12.

35. Madsen HO, Satz ML, Hogh B, Svejgaard A, Garred P. Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol. 1998;161:3169-75.

36. Babovic-Vuksanovic D, Snow K, Ten RM. Mannosebinding lectin (MBL) deficiency. Variant alleles in a midwestern population of the United States. Ann AllergyAsthma Immunol. 1999;82:134-8, 41; quiz 42-3.

37. Crosdale DJ, Ollier WE, Thomson W, et al. Mannose binding lectin (MBL) genotype distributions with relation to serum levels in UK Caucasoids. Eur J Immunogenet. 2000;27:111-7.

38. Takahashi K, Ip WE, Michelow IC, Ezekowitz RA. The mannose-binding lectin: a prototypic pattern recognition molecule. Curr Opin Immunol. 2006;18:16-23.

39. Schafranski MD, Pereira Ferrari L, Scherner D, Torres R, Jensenius JC, de Messias-Reason IJ. High-producing MBL2 genotypes increase the risk of acute and chronic carditis in patients with history of rheumatic fever. Mol Immunol. 2008;45:3827-31.

40. Nath SK, Kilpatrick J, Harley JB. Genetics of human systemic lupus erythematosus: the emerging picture. Curr Opin Immunol. 2004;16:794-800.

41. Monticielo OA, Mucenic T, Xavier RM, Brenol JC, Chies JA. The role of mannose-binding lectin in systemic lupus erythematosus. Clin Rheumatol. 2008;27:413-9.

42. White S, Rosen A. Apoptosis in systemic lupus erythematosus. Curr Opin Rheumatol. 2003;15:557-62.

43. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum. 1982;25:1271-7.

44. Freedman BI, Wilson CH, Spray BJ, Tuttle AB, Olorenshaw IM, Kammer GM. Familial clustering of end-stage renal disease in blacks with lupus nephritis. Am J Kidney Dis. 1997;29:729-32.

45. Garred P, Voss A, Madsen HO, Junker P. Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun. 2001;2:442-50.

46. Bertoli A, Fernández M, McGwin Jr G, et al. Systemic lupus erythematosus in a multiethnic US cohort: XXXVI. Influence of mannose-binding lectin exon 1 polymorphisms in disease manifestations, course, and outcome. Arthritis & Rheumatism. 2006;54:1703-4.

47. Hisano S, Matsushita M, Fujita T, Endo Y, Takebayashi S. Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis. Am J Kidney Dis. 2001;38:1082-8.